All Clinical Trials

Clinical Trial NCT04490915

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Crinecerfont (NBI-74788) in Pediatric Subjects with Classic Congenital Adrenal Hyperplasia, Followed by Open-Label Treatment

  • ClinicalTrials.gov ID: NCT04490915
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: PERRIN C WHITE

objective

N/A

If you are interested in this clinical trial, please contact Michelle Murphy on the Children’s Health Research Team.Call 972-754-4794Email